LIME TECHNOLOGY IKE

Their core work

LIME Technology is a Greek deep-tech SME focused on non-invasive imaging and diagnostic tools for bladder cancer. Their core work sits at the intersection of ultrasound, photoacoustic imaging, and 3D image reconstruction — technologies that allow clinicians to detect and characterize bladder tumors without invasive procedures. In the EDIT project they contributed to a multi-modal diagnostic platform combining nanomedicine with acoustic imaging; they then translated that experience into AIR3D, their own product initiative to build a minimum viable MVP for automated 3D bladder reconstruction from ultrasound data. In practical terms, they build or validate the software and hardware integration layers that turn raw acoustic signals into clinically usable diagnostic images.

What they specialise in

How they've shifted over time

LIME entered H2020 as a participant in a large FET Open RIA (EDIT, 2018), embedded in a broader consortium developing a multi-modal cancer diagnostic platform — their role there was contributing specific imaging or nanomedicine competencies within a larger scientific effort. By 2021 they had distilled that experience into a focused product initiative, coordinating AIR3D — a much smaller, commercially oriented CSA aimed at building an MVP for automated 3D bladder reconstruction. The shift from follower in a €3M+ consortium to lead coordinator of a targeted MVP project is a clear signal of growing product confidence and a transition from pure research contribution toward commercialization.

LIME is moving from research participant toward product developer, with a narrowing focus on turning ultrasound/photoacoustic data into automated, clinically deployable 3D imaging software — a path that could lead to medical device certification efforts.

How they like to work

With only two projects, LIME has filled both the participant and coordinator role — a rare balance for such a small organization, suggesting they are comfortable in either position depending on the project scope. Their consortia are small (10 unique partners across 2 projects, 4 countries), which is consistent with a specialist SME that joins targeted teams rather than broad multi-partner programs. Taking the coordinator role in AIR3D while still early in their EU project history suggests they are proactive in driving their own technology agenda.

LIME has worked with 10 unique partners across 4 countries, a modest but focused international footprint consistent with their tight technical niche. Their network spans Southern and possibly Central Europe, shaped by the FET Open call which typically attracts interdisciplinary teams from multiple EU member states.

What sets them apart

LIME occupies a narrow but commercially valuable niche: they combine acoustic imaging physics (ultrasound + photoacoustics) with software for automated 3D reconstruction, applied specifically to bladder oncology — a combination rarely held by a single SME rather than a hospital or large medtech company. For a consortium needing a technically credible, commercially motivated SME partner in acoustic-based cancer diagnostics, LIME brings validated FET Open project experience plus their own product development track, which means they are motivated to produce results that work outside the lab.

Highlights from their portfolio

• EDIT
  The highest-funded project for LIME (€298,570) and their entry into H2020 via a FET Open RIA — a competitive call — validating their technical credibility in multi-modal bladder cancer diagnostics.
• AIR3D
  Notable because LIME took the coordinator role, signaling a pivot from research partner to product owner, and because it represents an attempt to turn FET research into a marketable MVP.